Hui Wang

Years Active: 2022-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Deyan Luo, Hongxing Pan, Peng He, Xiaolan Yang, Tao Li, Nianzhi Ning, Xin Fang, Wenjing Yu, Mingwei Wei, Hui Gao, Xin Wang, Hongjing Gu, Maodong Mei, Xinwang Li, Liangyan Zhang, Deyu Li, Chunrun Gao, Jinbang Gao, Guoqiang Fei, Ying Li, Yuguo Yang, Yi Xu, Wenjin Wei, Yansong Sun, Fengcai Zhu, Zhongyu Hu, Hui Wang
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults. Clinical and translational medicine 12 (9) (2022)
Deyan Luo, Xiaolan Yang, Tao Li, Nianzhi Ning, Song Jin, Zhuangzhuang Shi, Hongjing Gu, Deyu Li, Yuwei Gao, Hui Wang
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants. Signal transduction and targeted therapy 7 (1) (2022)
Deyan Luo, Tao Li, Xiaolan Yang, Nianzhi Ning, Liangyan Zhang, Hongjing Gu, Deyu Li, Wenjing Yu, Zhongyu Hu, Hui Wang
The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection. Journal of medical virology (2022)
Meng Wang, Ying-Xian Goh, Cui Tai, Hui Wang, Zixin Deng, Hongping Qu
VRprofile2: detection of antibiotic resistance-associated mobilome in bacterial pathogens. Nucleic acids research (2022)

Hui Wang.css-eqlu8i{font-size:small;padding-left:4px;}